Loading clinical trials...
Loading clinical trials...
Validate speech analysis AI models: * To contrast the accuracy of acceXible's platform as a screening tool in the detection of people with cognitive impairment and mild dementia. * To evaluate the co...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Accexible
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT05592678 · Alzheimer's Disease (AD), Dementia, and more
NCT06051123 · ALSFTD, ALS (Amyotrophic Lateral Sclerosis), and more
NCT04896775 · Insomnia, Dementia
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
Centro de Prevención de Deterioro Cognitivo
Madrid, Madrid
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions